Clinical Trials Browser

Phase 1/2 × Mesothelioma, Malignant × Drug Therapy × Clear all

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Phase 1/2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT02649829 2025-04-29

MESODEC

Phase 1/2 Completed

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT01211275 2017-02-28

N08CPA

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma